Insmed | Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2025Q4 Dec/2025 -1.54 -1.28 -1.32 Feb/19 2026
FY2025Q3 Sep/2025 -1.75 -1.34 -1.27 Oct/30 2025
FY2025Q2 Jun/2025 -1.70 -1.36 -1.94 Aug/07 2025
FY2025Q1 Mar/2025 -1.42 -1.20 -1.06 May/08 2025
FY2024Q4 Dec/2024 -1.32 -1.18 -1.28 Feb/20 2025




Eps Cambiamento Data
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Cytokinetics USD -1.5 1.05 2025-12
DBV Technologies USD -0.24 1.31 2025-09
Gilead Sciences USD 1.86 0.61 2025-12
Heron Therapeutics USD -0.03 0.03 2024-09
Insmed USD -1.54 0.21 2025-12
Novartis USD 2.02 0.04 2025-09
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Sarepta Therapeutics USD -0.13 2.15 2025-09
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12


Insmed Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.